510(k) device
Kinesia
Cleveland Medical Devices, Inc. · Transducer, Tremor (GYD, Class II) · First FDA decision Apr 6, 2007, newest Apr 6, 2007Essential tremorParkinson's disease
Last checked: Nov 21, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
13
Naming "Kinesia"
MAUDE reports
0
Brand "Kinesia", since 2015
PubMed studies
121
Mentioning "Kinesia"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Kinesia
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- KINESIA510(k)
K063872 · Decided Apr 6, 2007 · 98 days after receipt
Device type: Transducer, Tremor (GYD) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Kinesia", any status and sponsor, newest update first.
- SMART-PD: Evaluating the Impact of Smartphone-Based Wearable Technology on Motor Symptoms and Quality of Life in People With Parkinson's DiseaseNot yet recruiting
Western UniversityAcademic, hospital or other
NCT07066163 · 32 participants (planned) · Start Jan 2026 · Primary completion Jan 2029
Device: Kinesia U · For: Parkinson Disease, Idiopathic
Sites: London, Canada · 2 sites in all
12 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Kinesia", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code GYD
3 reports: 3 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Kinesia"[tiab]. The summary above synthesizes these.
- Paradoxical kinesia may no longer be a paradox waiting for 100 years to be unraveled.
Melo-Thomas L, Schwarting RKW · Rev Neurosci · 2023Review, Research Support, Non-U.S. Gov't
- Paradoxical kinesia.
Daroff RB · Mov Disord · 2008Comment, Letter
- Parkinson's Kinesia Paradoxa Is Not a Paradox.
Duysens J, Nonnekes J · Mov Disord · 2021Research Support, Non-U.S. Gov't
- Correlation between Kinesia system assessments and clinical tremor scores in patients with essential tremor.
Mostile G, Giuffrida JP, Adam OR, et al. · Mov Disord · 2010Research Support, Non-U.S. Gov't
- Can stress trigger Parkinson's disease?
Djamshidian A, Lees AJ · J Neurol Neurosurg Psychiatry · 2014Research Support, Non-U.S. Gov't, Review
- Paradoxical kinesia in Parkinson's disease revisited: Anticipation of temporal constraints is critical.
Distler M, Schlachetzki JC, Kohl Z, et al. · Neuropsychologia · 2016Research Support, Non-U.S. Gov't
- Paradoxical kinesia induced by appetitive 50-kHz ultrasonic vocalizations in rats depends on glutamatergic mechanisms in the inferior colliculus.
Tonelli LC, Wöhr M, Schwarting R, et al. · Neuropharmacology · 2018Research Support, Non-U.S. Gov't
- Stress and cortisol in Parkinson's disease.
van Wamelen DJ, Wan YM, Ray Chaudhuri K, et al. · Int Rev Neurobiol · 2020Review
- Developing Theoretical Models of Kinesia Paradoxa Phenomenon in Order to Build Possible Therapeutic Protocols for Parkinson's Disease.
Banou I · Adv Exp Med Biol · 2023
- Paradoxical kinesia at war.
Schlesinger I, Erikh I, Yarnitsky D · Mov Disord · 2007Case Reports
- Clinically deployable Kinesia technology for automated tremor assessment.
Giuffrida JP, Riley DE, Maddux BN, et al. · Mov Disord · 2009Research Support, N.I.H., Extramural
- [Paradoxical kinesia in Parkinson's disease: theories and practical application].
Cozac VV, Rotaru L · Zh Nevrol Psikhiatr Im S S Korsakova · 2016Review
Other devices of this type
Also filed under product code GYD.
- Personal Kinetigraph (PKG) System Gen 2 PlusGkc Manufacturing Pty, Ltd. · 510(k) 2022
- Kneu Platform (V2)Kneu Health Digital , Ltd. · 510(k) 2026
- Empatica Health Monitoring Platform for Parkinson's Disease MonitoringEmpatica S.r.l. · 510(k) 2026
- Sine Monitoring Parkinsons Disease Tremor Dyskinesia Apple Watch (SMPDTDAW)Nordic Kinetics AB · 510(k) 2026
- Neu PlatformNeuhealth Digital , Ltd. · 510(k) 2025
- NeuroRPMNew Touch Digital, Inc. · 510(k) 2023
- Parky AppH2o Bilisim Yazilim · 510(k) 2022
- Rune Labs Tremor Transducer SystemRune Labs, Inc. · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.